Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by SOPHiA GENETICS

SOPHiA GENETICS’ SOPHiA DDM™ HRD Solution is Tapped by Unipath Specialty Laboratory Limited
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
SOPHiA GENETICS Celebrates Swiss Biotech Award
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
The University of Maryland Medical Center Chooses SOPHiA GENETICS Technology
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
Krsnaa Diagnostics is Live on SOPHiA GENETICS
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
Tel Aviv Sourasky Medical Center Chooses SOPHiA DDMTM HRD Solution of SOPHiA GENETICS
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
University of Arkansas for Medical Sciences Will Use SOPHiA GENETICS to Advance Clinical Research for Blood Cancers
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
SOPHiA GENETICS Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
Synergy Laboratories Taps SOPHiA GENETICS Technology for New Cancer Profiling Solution
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
SOPHiA GENETICS Expands Partnership With AstraZeneca to Include Multimodal Approaches for Cancer Drug Development
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference
From SOPHiA GENETICS
Via Business Wire
Tickers SOPH
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.